Author:
Schröer A.,Fischer D.,Lüdders D.,Diedrich K.,Friedrich M.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology
Reference34 articles.
1. Bristow RE, Lagasse LD, Karlan BY (1996) Secondary surgical cytoreduction for advanced epithelial ovarian cancer. Patient selection and review of the literature. Cancer 78: 2049–2062
2. Bokkel Huinink W ten, Gore M, Carmichael J et al. (1997) Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer. J Clin Oncol 15: 2183–2193
3. Burg MEL van der, Lent M van, Buyse M et al. for GCOG of the EORTC (1995) The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. N Engl J Med 332: 629–634
4. Burke TW, Morris M (1994) Secondary cytoreductive surgery for ovarian cancer. In: Gershenson DM (ed) Update on ovarian cancer. Obstetrics and gynecology clinics of North America, Vol 21. Saunders, Philadelphia, pp 167–178
5. Chen LM, Karlan BY (2000) Recurrent ovarian carcinoma: is there a place for surgery? Semin Surg Oncol 19: 62–68